Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the cardiovascular and sleep apnea markets, and show potential in several other indications, including cancer, addiction and neurodegenerative disease
and doses above 15 mg/kg result in complete dissociation with risk of cardiac arrest
Declining testosterone compounds this
In particular, the improvements in MI risk in semaglutide users appear to be diminished in younger populations, populations without a history of stroke/MI, and populations who self-reported as non-white, though none of these were determined to be significant interactions
As FBXO22 is an E3 ubiquitin ligase, the BPC157-FBXO22 complex likely regulates BACH1 protein levels by modulating its ubiquitination-mediated degradation